Formulary Chapter 9: Nutrition and blood - Full Chapter
|
09.01.04 |
Drugs used in autoimmune thrombocytopenic purpura |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
Status |
Description |

|
Primary and Secondary Care (unrestricted) – may be prescribed by GPs, hospital doctors or other qualified prescribers in primary and secondary care |

|
Amber Initiated: first prescription from specialist, on going supplies from primary care (or when stabilised on therapy). |

|
Amber recommended: first prescription may be supplied by primary care under the advice of a specialist. |

|
For initiation within a specialist service followed by ongoing prescribing in primary care according to published shared care guidance |

|
For initiation and ongoing prescribing in secondary care only. Medicines in this category may be further restricted to use by specific hospital departments only. |

|
For prescribing in primary care only |
|
|